Table 4 Quality of life assessment
Parameter | Before treatment (n = 58) | After treatment (n = 58) | χ2 | P value |
|---|---|---|---|---|
Sleep | ||||
Not troubled | 7 (12.06%) | 32 (55.17%) | Â | Â |
Moderately troubled | 40 (68.96%) | 21 (36.20%) | 32.34 | < 0.0001 |
Extremely troubled | 11 (18.96%) | 5 (8.62%) | Â | * |
Non-hay fever symptoms | ||||
Not troubled | 4 (18.96%) | 22 (70.68%) | Â | Â |
Moderately troubled | 46 (46.55%) | 29 (15.51%) | 16.38 | 0.003* |
Extremely troubled | 8 (34.48%) | 7 (13.79%) | Â | Â |
Practical problems | ||||
Not troubled | 15 (25.86%) | 44 (75.86%) | Â | Â |
Moderately troubled | 35 (60.34%) | 11 (18.96%) | 29.05 | < 0.0001 |
Extremely troubled | 8 (13.79%) | 3 (5.17%) | Â | * |
Nasal symptoms | ||||
Not troubled | 5 (8.62%) | 37 (63.79%) | 38.22 | < 0.0001 |
Moderately troubled | 31 (53.44%) | 12 (20.68%) | Â | * |
Extremely troubled | 22 (37.93%) | 9 (15.51%) | Â | Â |
Eye symptoms | ||||
Not troubled | 31(53.44%) | 45(77.58%) | Â | Â |
Moderately troubled | 22(37.93%) | 12(20.68%) | 8.18 | 0.014* |
Extremely troubled | 5(8.62%) | 1(1.72%) | Â | Â |